Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: A meta-analysis of randomized controlled trials

Advanced Pharmaceutical Bulletin

Volumn 8, Issue 4, 2018, Pages 565-574

  Mahboobi, Sepideh ^a   Rahimi, Fatemeh ^b   Jafarnejad, Sadegh ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Glycemic Status; Lipid Profile; Meta analysis; Prebiotic; Synbiotic

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PREBIOTIC AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL;

CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 85057729392     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2018.065     Document Type: Review

References (47)

1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011;8(4):228-36. doi: 10.1038/nrendo.2011.183
2. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59(8):750-5. doi: 10.1016/0002-9149(87)91086-1
3. Delzenne NM, Cani PD, Everard A, Neyrinck AM, Bindels LB. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 2015;58(10):2206-17. doi: 10.1007/s00125-015-3712-7
4. Moroti C, Souza Magri LF, de Rezende Costa M, Cavallini DC, Sivieri K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012;11:29. doi: 10.1186/1476-511X-11-29
5. Palau-Rodriguez M, Tulipani S, Isabel Queipo-Ortuño M, Urpi-Sarda M, Tinahones FJ, Andres-Lacueva C. Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol 2015;6:1151. doi: 10.3389/fmicb.2015.01151
6. Tilg H, Moschen AR. Microbiota and diabetes: An evolving relationship. Gut 2014;63(9):1513-21. doi: 10.1136/gutjnl-2014-306928
7. Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA. Effects of a multispecies probiotic supplement on bone health in osteopenic postmenopausal women: A randomized, double-blind, controlled trial. J Am Coll Nutr 2017;36(7):497-506. doi: 10.1080/07315724.2017.1318724
8. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing lactobacillus acidophilus and lactobacillus casei in high fructose fed rats. Nutrition 2007;23(1):62-8. doi: 10.1016/j.nut.2006.09.002
9. Yun SI, Park HO, Kang JH. Effect of lactobacillus gasseri bnr17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009;107(5):1681-6. doi: 10.1111/j.1365-2672.2009.04350.x
10. Yadav H, Jain S, Sinha PR. Oral administration of dahi containing probiotic lactobacillus acidophilus and lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res 2008;75(2):189-95. doi: 10.1017/S0022029908003129
11. Andersson U, Branning C, Ahrne S, Molin G, Alenfall J, Onning G, et al. Probiotics lower plasma glucose in the high-fat fed c57bl/6j mouse. Benef Microbes 2010;1(2):189-96. doi: 10.3920/BM2009.0036
12. Roberfroid MB. Prebiotics and probiotics: Are they functional foods? Am J Clin Nutr 2000;71(6):1682s-7s. doi: 10.1093/ajcn/71.6.1682S
13. Kellow NJ, Coughlan MT, Savige GS, Reid CM. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: A study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord 2014;14:55. doi: 10.1186/1472-6823-14-55
14. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001;73(2):361s-4s. doi: 10.1093/ajcn/73.2.361s
15. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014;33(2):198-203. doi: 10.1016/j.clnu.2013.05.015
16. Shakeri H, Hadaegh H, Abedi F, Tajabadi-Ebrahimi M, Mazroii N, Ghandi Y, et al. Consumption of synbiotic bread decreases triacylglycerol and vldl levels while increasing hdl levels in serum from patients with type-2 diabetes. Lipids 2014;49(7):695-701. doi: 10.1007/s11745-014-3901-z
17. Thompson LU, Jenkins DJ, Amer MA, Reichert R, Jenkins A, Kamulsky J. The effect of fermented and unfermented milks on serum cholesterol. Am J Clin Nutr 1982;36(6):1106-11. doi: 10.1093/ajcn/36.6.1106
18. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000;54(4):288-97. doi: 10.1038/sj.ejcn.1600937
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009;151(4):W-65-94. doi: 10.7326/0003-4819-151-4-200908180-00136
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17(1):1-12. doi: 10.1016/0197-2456(95)00134-4
21. Ebrahimi ZS, Nasli-Esfahani E, Nadjarzade A, Mozaffari-khosravi H. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: A randomized, double-blind, clinical trial. J Diabetes Metab Disord 2017;16:23. doi: 10.1186/s40200-017-0304-8
22. Pourghassem Gargari B, Namazi N, Khalili M, Sarmadi B, Jafarabadi MA, Dehghan P. Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes? Complement Ther Med 2015;23(6):810-5. doi: 10.1016/j.ctim.2015.09.005
23. Dehghan P, Farhangi MA, Tavakoli F, Aliasgarzadeh A, Akbari AM. Impact of prebiotic supplementation on t-cell subsets and their related cytokines, anthropometric features and blood pressure in patients with type 2 diabetes mellitus: A randomized placebo-controlled trial. Complement Ther Med 2016;24:96-102. doi: 10.1016/j.ctim.2015.12.010
24. Dehghan P, Pourghassem Gargari B, Asgharijafarabadi M. Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: A randomized, placebo-controlled clinical trial. Health Promot Perspect 2013;3(1):55-63. doi: 10.5681/hpp.2013.007
25. Bonsu NK, Johnson S. Effects of inulin fiber supplementation on serum glucose and lipid concentration in patients with type 2 diabetes. Int J Diabetes Metab 2012;21:80-6.
26. Luo J, Van Yperselle M, Rizkalla SW, Rossi F, Bornet FR, Slama G. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000;130(6):1572-7. doi: 10.1093/jn/130.6.1572
27. Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, Asghari Jafar-abadi M. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 2013;37(2):140-8. doi: 10.4093/dmj.2013.37.2.140
28. Hosseini B, Nourmohamadi M, Hajipour S, Taghizadeh M, Asemi Z, Keshavarz SA, et al. The effect of omega-3 fatty acids, epa, and/or dha on male infertility: A systematic review and meta-analysis. J Diet Suppl 2018:1-12. doi: 10.1080/19390211.2018.1431753
29. Jafarnejad S, Keshavarz SA, Mahbubi S, Saremi S, Arab A, Abbasi S, et al. Effect of ginger (Zingiber officinale) on blood glucose and lipid concentrations in diabetic and hyperlipidemic subjects: A meta-analysis of randomized controlled trials. J Funct Foods 2017;29:127-34. doi: 10.1016/j.jff.2016.12.006
30. Jafarnejad S, Tsang C, Taghizadeh M, Asemi Z, Keshavarz SA. A meta-analysis of cumin (Cuminum cyminim L.) consumption on metabolic and anthropometric indices in overweight and type 2 diabetics. J Funct Foods 2018;44:313-21. doi: 10.1016/j.jff.2018.03.026
31. Dehghan P, Pourghassem Gargari B, Jafar-Abadi MA, Aliasgharzadeh A. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized-controlled clinical trial. Int J Food Sci Nutr 2014;65(1):117-23. doi: 10.3109/09637486.2013.836738
32. Beserra BT, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin Nutr 2015;34(5):845-58. doi: 10.1016/j.clnu.2014.10.004
33. Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F, et al. The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob Proteins 2018;10(2):329-42. doi: 10.1007/s12602-017-9299-1
34. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013;143(3):324-31. doi: 10.3945/jn.112.166132
35. Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study. Eur J Clin Nutr 2005;59(5):723-6. doi: 10.1038/sj.ejcn.1602127
36. Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: A randomised, double-blind, placebo-controlled pilot study. Br J Nutr 2014;112(3):438-45. doi: 10.1017/S0007114514000919
37. Guess ND, Dornhorst A, Oliver N, Bell JD, Thomas EL, Frost GS. A randomized controlled trial: The effect of inulin on weight management and ectopic fat in subjects with prediabetes. Nutr Metab (Lond) 2015;12:36. doi: 10.1186/s12986-015-0033-2
38. Kellow NJ, Coughlan MT, Reid CM. Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. Br J Nutr 2014;111(7):1147-61. doi: 10.1017/S0007114513003607
39. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011;60(11):2775-86. doi: 10.2337/db11-0227
40. Yamashita K, Kawai K, Itakura M. Effects of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 1984;4(6):961-6. doi: 10.1016/S0271-5317(84)80075-5
41. Davidson MH, Maki KC, Synecki C, Torri SA, Drennan KB. Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia. Nutr Res 1998;18(3):503-17. doi: 10.1016/S0271-5317(98)00038-4
42. Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, et al. Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2008;62(2):232-7. doi: 10.1038/sj.ejcn.1602719
43. Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int J Mol Sci 2010;11(6):2499-522. doi: 10.3390/ijms11062499
44. Delzenne NM, Cani PD, Neyrinck AM. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: Experimental data. J Nutr 2007;137(11):2547S-51S. doi: 10.1093/jn/137.11.2547S
45. Pereira DI, McCartney AL, Gibson GR. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol 2003;69(8):4743-52. doi: 10.1128/aem.69.8.4743-4752.2003
46. Arora T, Sharma R, Frost G. Propionate. Anti-obesity and satiety enhancing factor? Appetite 2011;56(2):511-5. doi: 10.1016/j.appet.2011.01.016
47. Williams CM. Effects of inulin on lipid parameters in humans. J Nutr 1999;129(7):1471S-3s. doi: 10.1093/jn/129.7.1471S